Literature DB >> 17592090

Diabetic cardiomyopathy revisited.

Sihem Boudina1, E Dale Abel.   

Abstract

Diabetes mellitus increases the risk of heart failure independently of underlying coronary artery disease, and many believe that diabetes leads to cardiomyopathy. The underlying pathogenesis is partially understood. Several factors may contribute to the development of cardiac dysfunction in the absence of coronary artery disease in diabetes mellitus. This review discusses the latest findings in diabetic humans and in animal models and reviews emerging new mechanisms that may be involved in the development and progression of cardiac dysfunction in diabetes.

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17592090     DOI： 10.1161/CIRCULATIONAHA.106.679597

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


  577 in total

1.  Bioenergetic effects of mitochondrial-targeted coenzyme Q analogs in endothelial cells.

Authors:  Brian D Fink; Judith A Herlein; Mark A Yorek; Amanda M Fenner; Robert J Kerns; William I Sivitz
Journal:  J Pharmacol Exp Ther       Date:  2012-06-01       Impact factor: 4.030

2.  [Aerobic and strength training in patients with diabetes mellitus type 2 and heart failure].

Authors:  D Niederseer; J Niebauer
Journal:  Herz       Date:  2012-08       Impact factor: 1.443

3.  Enhancing fatty acid oxidation negatively regulates PPARs signaling in the heart.

Authors:  ZhengLong Liu; Jeffrey Ding; Timothy S McMillen; Outi Villet; Rong Tian; Dan Shao
Journal:  J Mol Cell Cardiol       Date:  2020-06-24       Impact factor: 5.000

4.  Diabetic Cardiomyopathy: Mechanisms and Therapeutic Targets.

Authors:  Pavan K Battiprolu; Thomas G Gillette; Zhao V Wang; Sergio Lavandero; Joseph A Hill
Journal:  Drug Discov Today Dis Mech       Date:  2010

5.  Potentiation of abnormalities in myocardial metabolism with the development of diabetes in women with obesity and insulin resistance.

Authors:  Janet B McGill; Linda R Peterson; Pilar Herrero; Ibrahim M Saeed; Carol Recklein; Andrew R Coggan; Amanda J Demoss; Kenneth B Schechtman; Carmen S Dence; Robert J Gropler
Journal:  J Nucl Cardiol       Date:  2011-04-23       Impact factor: 5.952

6.  Left atrium passive ejection fraction is the most sensitive index of type 2 diabetes mellitus-related cardiac changes.

Authors:  Yongning Shang; Xiaochun Zhang; Weiling Leng; Xiaotian Lei; Liu Chen; Ziwen Liang; Jian Wang
Journal:  Int J Cardiovasc Imaging       Date:  2017-07-18       Impact factor: 2.357

7.  Contribution of impaired myocardial insulin signaling to mitochondrial dysfunction and oxidative stress in the heart.

Authors:  Sihem Boudina; Heiko Bugger; Sandra Sena; Brian T O'Neill; Vlad G Zaha; Olesya Ilkun; Jordan J Wright; Pradip K Mazumder; Eric Palfreyman; Timothy J Tidwell; Heather Theobald; Oleh Khalimonchuk; Benjamin Wayment; Xiaoming Sheng; Kenneth J Rodnick; Ryan Centini; Dong Chen; Sheldon E Litwin; Bart E Weimer; E Dale Abel
Journal:  Circulation       Date:  2009-02-23       Impact factor: 29.690

Review 8.  Cardiac dysfunction and oxidative stress in the metabolic syndrome: an update on antioxidant therapies.

Authors:  Olesya Ilkun; Sihem Boudina
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.116

Review 9.  Is diabetic cardiomyopathy a specific entity?

Authors:  Mitja Letonja; Danijel Petrovič
Journal:  World J Cardiol       Date:  2014-01-26

10.  Mitochondrial remodeling in mice with cardiomyocyte-specific lipid overload.

Authors:  Aly Elezaby; Aaron L Sverdlov; Vivian H Tu; Kanupriya Soni; Ivan Luptak; Fuzhong Qin; Marc Liesa; Orian S Shirihai; Jamie Rimer; Jean E Schaffer; Wilson S Colucci; Edward J Miller
Journal:  J Mol Cell Cardiol       Date:  2014-12-09       Impact factor: 5.000
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.